Satsuma Drug Patent Portfolio
Satsuma owns 1 orange book drug protected by 6 US patents Given below is the list of Satsuma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11744967 | Intranasal delivery devices | 12 Oct, 2041 | Active |
| US12102754 | Intranasal delivery devices | 12 Oct, 2041 | Active |
| US10758532 | Compositions, devices, and methods for treating or preventing headaches | 11 Dec, 2039 | Active |
| US12263162 | Compositions, devices, and methods for treating or preventing headaches | 11 Dec, 2039 | Active |
| US10792253 | Pharmaceutical compositions | 04 Aug, 2037 | Active |
| US11872314 | Pharmaceutical compositions | 04 Aug, 2037 | Active |
Latest Legal Activities on Satsuma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Satsuma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent eGrant | 01 Apr, 2025 | US12263162 |
| Email Notification | 01 Apr, 2025 | US12263162 |
| Patent Issue Date Used in PTA Calculation | 01 Apr, 2025 | US12263162 |
| Mail Patent eGrant Notification | 01 Apr, 2025 | US12263162 |
| Patent eGrant Notification | 01 Apr, 2025 | US12263162 |
| Recordation of Patent Grant Mailed | 01 Apr, 2025 | US12263162 |
| Email Notification | 13 Mar, 2025 | US12263162 |
| Issue Notification Mailed | 12 Mar, 2025 | US12263162 |
| Mail Response to 312 Amendment (PTO-271) | 27 Feb, 2025 | US12263162 |
| Email Notification | 27 Feb, 2025 | US12263162 |
| Application Is Considered Ready for Issue | 26 Feb, 2025 | US12263162 |
| Dispatch to FDC | 26 Feb, 2025 | US12263162 |
| Response to Amendment under Rule 312 | 21 Feb, 2025 | US12263162 |
| Pubs Case Remand to TC | 20 Feb, 2025 | US12263162 |
| Issue Fee Payment Verified | 19 Feb, 2025 | US12263162 |
Satsuma's Family Patents
Satsuma Drug List
Given below is the complete list of Satsuma's drugs and the patents protecting them.
1. Atzumi
Atzumi is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11744967 | Intranasal delivery devices |
12 Oct, 2041
(15 years from now)
| Active |
| US12102754 | Intranasal delivery devices |
12 Oct, 2041
(15 years from now)
| Active |
| US10758532 | Compositions, devices, and methods for treating or preventing headaches |
11 Dec, 2039
(13 years from now)
| Active |
| US12263162 | Compositions, devices, and methods for treating or preventing headaches |
11 Dec, 2039
(13 years from now)
| Active |
| US10792253 | Pharmaceutical compositions |
04 Aug, 2037
(11 years from now)
| Active |
| US11872314 | Pharmaceutical compositions |
04 Aug, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atzumi's drug page